Using Pure PDGF For Healthy Regeneration and Rejuvenation

Course Description:

Recombinant pure platelet-derived growth factor (rhPDGF-BB) is the only pure off-the-shelf growth factor to receive FDA approval for multiple soft tissue and bone regeneration applications, including periodontal and maxillofacial indications. Ariessence pure PDGF+ has also recently gained tremendous popularity in facial aesthetic medicine among dermatologist, plastic surgeons and med spa providers. It is now the fastest growing regenerative technology in aesthetic medicine. It is estimated that the application of rhPDGF-BB has enhanced treatment outcomes in over 5 million patients worldwide. Dr. Lynch will share the story of PDGF discovery and development, highlight the milestones in his career as a translational medicine scientist and entrepreneur leading to four FDA approved regenerative products, and present many clinical cases using rhPDGF-BB in facial aesthetics and maxillofacial surgery. Most importantly, he will be available to answer your questions regarding how to utilize pure rhPDGF-BB in your office.

Course Objectives:

Attendees will gain a deeper understanding of:
1. How pure rhPDGF-BB is used throughout regenerative medicine;
2. How pure rhPDGF-BB was developed as a broad regenerative therapeutic;
3. How pure rhPDGF-BB is currently being used in facial aesthetics.

Take Home Messages From Dr. Lynch:

1. Science is sexy: Embrace scientific discovery when talking with your patients.
2. Regenerative medicine is an important tool in your armentarium.
3. Incorporating Pure PDGF into your treatment regimen can help you generate better, faster patient results while being less hassle for you and a time saver for your staff compared to many other alternative therapies.

SAMUEL LYNCH, DMSc, DMD, was a pioneer in regenerative medicine before it was a buzz word. He is one of the world’s foremost authorities on growth factors, particularly platelet-derived growth factor (PDGF), for tissue regeneration. He has over 250 publications and patents, and has given hundreds of lectures in over 25 countries. He consulted with J&J on the development of Regranex (rhPDGF-BB) Gel to improve the healing of diabetic foot ulcers, and is the inventor and led the development of multiple FDA approved regenerative medicine products, including GEM 21S for periodontal and oral surgery tissue regeneration, Augment Bone Graft and Augment Injectable for use as an alternative to autogenous bone from the iliac crest or proximal tibia in orthopedic bone fusions, and most recently developed ariessence pure PDGF+ for use in aesthetic medicine.